Cambridge, United Kingdom

Neil Anthony Pegg

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Neil Anthony Pegg

Introduction

Neil Anthony Pegg is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. With a total of five patents to his name, Pegg's work is recognized for its potential impact on cancer therapies.

Latest Patents

Among his latest patents, Pegg has developed pharmaceutical compounds that include an arylimidazolyl isoxazole of a specific formula. This compound, or its pharmaceutically acceptable salt, has shown activity in modulating the activity of p300 and/or CBP. It is particularly aimed at treating cancer, with a focus on prostate cancer.

Career Highlights

Pegg is currently associated with Cellcentric Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing cancer treatment options through novel compounds.

Collaborations

Some of Pegg's notable coworkers include David Michel, Adrien Taddei, and Richard James Brown. Their collaborative efforts contribute to the ongoing research and development in the field of pharmaceuticals.

Conclusion

Neil Anthony Pegg's contributions to pharmaceutical innovations highlight his dedication to improving cancer treatment. His patents reflect a significant advancement in the modulation of cancer-related pathways, showcasing the importance of his work in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…